Top compounds associated with response to RASL10B


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA apicidin CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA pac-1 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA Topotecan CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA PI-103 CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA manumycin A CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.11 0.0007
Download CSV